|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 近40年内蒙古候平均气温变化趋势显示文摘基于1964—2003年内蒙古有关台站的逐日气温数据,对前20年(1964—1983年)和后20年(1984—2003年)的候平均气温中值进行了对比,并利用k-means方法进行了候平均气温变化趋势的聚类分析,旨在阐明内蒙古气温变化的时空特点和规律。研究结果表明:内蒙古全境年平均气温普遍上升,没有下降的现象。不同地区、不同季节气温变化格局不同,北部变暖比南部更为明显,冬季和夏末秋初变暖出现得更频繁。绝大部分地区大多数候平均气温都有所上升,而且候平均气温变化存在纬向地带性。大多数台站四季里都有一些显著升温的候,显著升温在冬季发生得更为频繁。同时,有少数几个候出现气温下降的现象,但未达到显著下降的程度。内蒙古绝大部分地区候最高、最低气温都有所升高,但二者的差值在缩小。候最低气温出现时间有所提前,候最高气温出现时间有提前也有推迟,但总体上不同地区候最高、最低气温出现时间更加同步。因此,候最高、最低气温的时空均一性有所增强。候最高气温出现时间与候最低气温出现时间的间隔有扩大迹象。总之,全球气候变暖降低了气温的季节和地区差异。 | 裴浩 Alex Cannon Paul Whitfield 郝璐 | 2009 | 应用气象学报2009,20,4: | 19 |
| 2 | Bemisia tabaci: The current situation in the UK and the prospect of developing strategies for eradication using entomopathogens显示文摘sweetpotato whitefly, Bemisia tabaci (Gennadius )( 半翅类:Aleyrodidae ) 仍然是严肃的威胁到世界范围的庄稼。因为它是从几个家庭的超过 111 个病毒的有效向量,损坏 B 遗传因子型具有特定的经济担心,特别地 geminiviruses。Bemisia tabaci 定期在进入它受到根除的一条政策的英国的植物上被拦截。英国对这个害虫维持保护的地区地位。B 的入口的一条主要小径。进保护的地区的 tabaci 涉及宣传材料,特别一品红(大戟属植物 pulcherrima ) 。连续地与增加的杀虫药剂电阻被记录, B。tabaci 对控制 / 根除正在变得更困难。包含 entomopathogenic 线虫和真菌的最近的研究为这个害虫为控制程序的开发正在显示出许多潜力。线虫 Steinernema feltiae 和真菌 Lecanicillium muscarium 被显示了对第二中间形态 B 很有效。tabaci。要求的环境条件调整也增加了他们的功效。entomopathogens 也显示出与化学杀虫药剂的相容性的高水平,都增加他们的潜力对 B 被合并到控制策略。tabaci。 | Andrew G. S. Cuthbertson Lisa F. Blackburn Dominic P. Eyre Raymond J.C. Cannon Judith Miller Phil Northing | 2011 | Insect Science2011,18,1: | 8 |
| 3 | Blood glucose changes surrounding initiation of tumor-necrosis factor inhibitors and conventional disease-modifying anti-rheumatic drugs in veterans with rheumatoid arthritis显示文摘AIM To determine the scope of acute hypoglycemic effects for certain anti-rheumatic medications in a large retrospective observational study. METHODS Patients enrolled in the Veterans Affairs Rheumatoid Arthritis (VARA) registry were selected who, during follow-up, initiated treatment with tumor necrosis factor inhibitors (TNFi's, including etanercept, adalimumab, infliximab, golimumab, or certolizumab), prednisone, or conventional disease-modifying anti-rheumatic drugs(DMARDs), and for whom proximate random blood glucose (RBG) measurements were available within a window 2-wk prior to, and 6 mo following, medication initiation. Similar data were obtained for patients with proximate values available for glycosylated hemoglobin A1C values within a window 2 mo preceding, and 12 mo following, medication initiation. RBG and A1C measurements were compared before and after initiation events using paired t-tests, and multivariate regression analysis was performed including established comorbidities and demographics.RESULTS Two thousands one hundred and eleven patients contributed at least one proximate measurement surrounding the initiation of any examined medication. A significant decrease in RBG was noted surrounding 653 individual hydroxychloroquine-initiation events(-3.68 mg/dL, P = 0.04), while an increase was noted for RBG surrounding 665 prednisone-initiation events(+5.85 mg/d L, P < 0.01). A statistically significant decrease in A1C was noted for sulfasalazine initiation, as measured by 49 individual initiation events(-0.70%, P < 0.01). Multivariate regression analyses, using methotrexate as the referent, suggest sulfasalazine (β =-0.58, P = 0.01) and hydroxychloroquine(β =-5.78, P = 0.01) use as predictors of lower post-medicationinitiation RBG and A1C values, respectively. Analysis by drug class suggested prednisone (or glucocorticoids) as predictive of higher medication-initiation event RBG among all start events as compared to DMARDs, while this analysis did not show any drug class-level effect for TNFi. A diagnosis of congestive heart failure(β = 4.69, P = 0.03) was predictive for higher post-initiation RBG values among all medication-initiation events.CONCLUSION No statistically significant hypoglycemic effects surrounding TNFi initiation were observed in this large cohort. Sulfasalazine and hydroxychloroquine may have epidemiologically significant acute hypoglycemic effects. | Patrick R Wood Evan Manning Joshua F Baker Bryant England Lisa Davis Grant W Cannon Ted R Mikuls Liron Caplan | 2018 | World Journal of Diabetes2018,9,2: | 8 |
| 4 | 苍耳柄锈菌三裂叶豚草专化型的超微结构观察(英文)显示文摘20 0 3年在沈阳的三裂叶豚草 (AmbrosiatrifidaL .)上发现了苍耳柄锈菌三裂叶豚草专化型 (PucciniaxanthiiSchwein .f.sp .ambrosia trifidaeS .W .T .Batra) ,这是在我国三裂叶豚草上发现的一种新病菌。试验采用扫描电镜和透射电镜对该锈菌的冬孢子和吸器的形态结构进行了观察。 | 吕国忠 杨红 曲波 黄国坤 陈伟之 Paul Cannon | 2004 | 菌物研究2004,2,2: | 6 |
| 5 | TIMI Frame Count: A Quantitative Method of Assessing Coronary Artery Flow显示文摘 | C. Michael Gibson Christopher P. Cannon William L. Daley Jr Dodge Barbara Alexander Susan J. Marble Carolyn H. McCabe Lori Raymond Terry Fortin W. Kenneth Poole Eugene Braunwald | 1996 | Circulation1996,,5: | 6 |
| 6 | 急性冠状动脉综合征发生1个月后的生长分化因子15水平与主要出血风险增加相关显示文摘用双重抗血小板治疗的急性冠状动脉综合征(acutecoronarysyndromes,ACS)患者在初次就诊测量的生长分化因子15(growthdifferentiationfactor-15,GDF-15)与大出血相关。 | Lindholm D Hagstrm E James SK Becker RC Cannon CP Himmelmann A Katus HA Maurer G López-Sendón JL Steg PG Storey RF Siegbahn A Wallentin L 刘莉 叶鹏 | 2017 | 中华高血压杂志2017,25,5: | 5 |
| 7 | Further compatibility tests of the entomopathogenic fungus Lecanicillium muscarium with conventional insecticide products for control of sweetpotato whitefly, Bemisia tabaci on poinsettia plants显示文摘为鸡蛋的控制和甘薯白人的第二个中间形态阶段为 24 h 跟随直接暴露到杀虫药剂 Majestik,水花油, Agri-50E, Savona 和天王卫四的 entomopathogenic 真菌 Lecanicillium muscarium 的孢子萌芽上的效果飞, Bemisia tabaci,被决定。到 Agri-50E 和天王卫四的暴露被可接受的孢子萌芽跟随。L 的传染性率。一品红叶子上的 muscarium 也面对杀虫药剂的干燥残余被调查。B 的控制的没有重要有害效果 on the levels。tabaci 与用于没有残余的叶子的真菌相比被记录。有真菌的化学药品 Savona,水花油和 Majestik 的顺序的申请都生产了第二中间形态 B 的死亡。超过 90% 的 tabaci。有 L 的这些化学药品的加入。muscarium 进为 B 的综合防治法节目。tabaci 被讨论。 | Andrew G. S. Cuthbertson Lisa F. Blackburn Phil Northing Weiqi Luo Raymond J. C. Cannon Keith F. A. Waiters | 2008 | Insect Science2008,15,4: | 5 |
| 8 | Evaluation of a laparoscopic liver resection in the setting of cirrhosis显示文摘 | Robert M Cannon Bob Saggi Joseph F Buell | 2014 | HPB2014,,2: | 3 |
| 9 | Evaluation of stapler hepatectomy during a laparoscopic liver resection显示文摘 | Joseph F. Buell Brice Gayet Ho‐Seong Han Go Wakabayashi Ki‐Hun Kim Giulio Belli Robert Cannon Bob Saggi Hiro Keneko Alan Koffron Guy Brock Ibrahim Dagher | 2013 | HPB2013,,11: | 3 |
| 10 | 碳青霉烯类抗生素引发癫痫发作风险:一项荟萃分析显示文摘碳青霉烯类是一种广谱抗生素,常用于复杂和严重的细菌感染。多数患者对碳青霉烯类抗生素耐受性良好。临床医师通常认为在碳青霉烯类抗生素中亚胺培南最易引发癫痫发作,这一点在文献中尚存在争议。根据美国FDA 批准的药物说明书,亚胺培南、美罗培南和厄他培南诱发癫痫发作的频率分别为0.4%、0.7%和0.5%。文章荟萃分析碳青霉烯类引发癫痫发作的随机对照研究,以评估不同品种碳青霉烯类抗生素导致癫痫发作的风险,直接比较各碳青霉烯类引发癫痫发作的风险。 | Cannon JP Lee TA Clark NM 肖广辉 汪复 | 2015 | 中国感染与化疗杂志2015,15,3: | 3 |
| 11 | Population-Based Family History–Specific Risks for Colorectal Cancer: A Constellation Approach显示文摘 | David P. Taylor Randall W. Burt Marc S. Williams Peter J. Haug Lisa A. Cannon–Albright | 2010 | Gastroenterology2010,,3: | 3 |
| 12 | 根据基础降压用药分析恩格列净在2型糖尿病合并高血压患者中的降压作用显示文摘在EMPA—REG血压试验中,与安慰剂比较,恩格列净(empagliflozin)10或25mg/d可降低2型糖尿病合并高血压患者的糖化血红蛋白、血压及体质量水平。 | Mancia G Cannon CP Tikkanen I Zeller C Ley L Woerle HJ Broedl UC Johansen OE 赵狄 练桂丽 | 2016 | 中华高血压杂志2016,24,10: | 3 |
| 13 | 阿司匹林和溶栓疗法加用氯吡格雷治疗ST段抬高心肌梗死 | Sabatine M.S. Cannon C.P. Gibson C.M. 任付先 | 2005 | 世界核心医学期刊文摘(心脏病学分册)2005,0,9: | 3 |
| 14 | Intensive versus moderate lipid lowering with statins after acute coronary syndromes显示文摘 | Cannon CP Braunwald E McCabe CH | | New England Journal of Medicine0,,: | 3 |
| 15 | Gastrointestinal and hepatic complications of hematopoietic stem cell transplantation显示文摘Recognition and management of gastrointestinal and hepatic complications of hematopoietic stem cell transplantation has gained increasing importance as indications and techniques of transplantation have expanded in the last few years.The transplant recipient is at risk for several complications including conditioning chemotherapy related toxicities,infections,bleeding,sinusoidal obstruction syndrome,acute and chronic graftversus-host disease(GVHD) as well as other long-term problems.The severity and the incidence of many complications have improved in the past several years as the intensity of conditioning regimens has diminished and better supportive care and GVHD prevention strategies have been implemented.Transplant clinicians,however,continue to be challenged with problems arising from human leukocyte antigen-mismatched and unrelated donor transplants,expanding transplant indications and age-limit.This review describes the most commonly seen transplant related complications,focusing on their pathogenesis,differential diagnosis and management. | Hande H Tuncer Naveed Rana Cannon Milani Angela Darko Samer A AlHomsi | 2012 | World Journal of Gastroenterology2012,18,16: | 3 |
| 16 | Reduction in Recurrent Cardiovascular Events With Intensive Lipid-Lowering Statin Therapy Compared With Moderate Lipid-Lowering Statin Therapy After Acute Coronary Syndromes显示文摘 | Sabina A. Murphy Christopher P. Cannon Stephen D. Wiviott Carolyn H. McCabe Eugene Braunwald | 2009 | Journal of the American College of Cardiology2009,,25: | 3 |
| 17 | Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease – is this type 3 diabetes?显示文摘 | Eric Steen Benjamin M. Terry Enrique J. Rivera Jennifer L. Cannon Thomas R. Neely Rose Tavares X. Julia Xu Jack R. Wands Suzanne M. de la Monte | 2005 | Journal of Alzheimer’s Disease2005,,1: | 3 |
| 18 | Extracorporeal membrane oxygenation in lung transplantation:Indications,techniques and results显示文摘The use of extracorporeal membrane oxygenation(ECMO)in the field of lung transplantation has rapidly expanded over the past 30 years.It has become an important tool in an increasing number of specialized centers as a bridge to transplantation and in the intra-operative and/or post-operative setting.ECMO is an extremely versatile tool in the field of lung transplantation as it can be used and adapted in different configurations with several potential cannulation sites according to the specific need of the recipient.For example,patients who need to be bridged to lung transplantation often have hypercapnic respiratory failure that may preferably benefit from veno-venous(VV)ECMO or peripheral veno-arterial(VA)ECMO in the case of hemodynamic instability.Moreover,in an intraoperative setting,VV ECMO can be maintained or switched to a VA ECMO.The routine use of intra-operative ECMO and its eventual prolongation in the postoperative period has been widely investigated in recent years by several important lung transplantation centers in order to assess the graft function and its potential protective role on primary graft dysfunction and on ischemia-reperfusion injury.This review will assess the current evidence on the role of ECMO in the different phases of lung transplantation,while analyzing different studies on pre,intra-and post-operative utilization of this extracorporeal support. | Eleonora Faccioli Stefano Terzi Alessandro Pangoni Ivan Lomangino Sara Rossi Andrea Lloret Giorgio Cannone Carlotta Marino Chiara Catelli Andrea Dell'Amore | 2021 | World Journal of Transplantation2021,11,7: | 3 |
| 19 | Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial显示文摘 | Michael Miller Christopher P. Cannon Sabina A. Murphy Jie Qin Kausik K. Ray Eugene Braunwald | 2008 | Journal of the American College of Cardiology2008,,7: | 2 |
| 20 | Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401显示文摘 | Pasquale Comella Bruno Massidda Gianfranco Filippelli Antonio Farris Donato Natale Giuseppe Barberis Luigi Maiorino Sergio Palmeri Michele Cannone Giovanni Condemi | 2009 | Journal of Cancer Research and Clinical Oncology2009,,2: | 2 |